Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-16383

Single-particle
2.9 Å
EMD-16383 Deposition: 21/12/2022
Map released: 19/04/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16383

Cryo-EM map of SARS-CoV-2 S-trimer (3 RBDs up) in complex with neutralizing sherpabody TriSb92

EMD-16383

Single-particle
2.9 Å
EMD-16383 Deposition: 21/12/2022
Map released: 19/04/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 Spike in open conformation with bound sherpabody
Fitted models: 8c1v

Deposition Authors: Huiskonen JT , Rissanen I , Hannula L
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
PUBMED: 36964125
DOI: doi:10.1038/s41467-023-37290-6
ISSN: 2041-1723
Grant Support: